Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

7.87
+0.27003.55%
Pre-market: 7.880.0100+0.13%06:37 EDT
Volume:1.11M
Turnover:8.59M
Market Cap:456.72M
PE:-0.75
High:8.09
Open:7.68
Low:7.47
Close:7.60
Loading ...

Applied DNA Sciences trading halted, news pending

TIPRANKS
·
14 Mar

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

PR Newswire
·
14 Mar

Donaco International's (ASX:DNA) Earnings Are Weaker Than They Seem

Simply Wall St.
·
07 Mar

Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why

Zacks
·
06 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

Singaporean woman killed in Spain: DNA from two men found on victim's clothes

CNA
·
04 Mar

Stock Track | Ginkgo Bioworks Plummets 5% as 2024 Earnings Miss Expectations, Revenue Declines

Stock Track
·
28 Feb

Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)

TIPRANKS
·
28 Feb

First Community Credit Union Selects the Fiserv award-winning DNA Platform to Stay on Cutting Edge of Banking Technology

Business Wire
·
27 Feb

Ginkgo Bioworks Holdings Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
27 Feb

BUZZ-Ginkgo Bioworks falls on downbeat 2025 forecast

Reuters
·
27 Feb

Ginkgo Bioworks falls -12.5%

TIPRANKS
·
26 Feb

IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19

GlobeNewswire
·
26 Feb

US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert

Benzinga
·
26 Feb

William Blair Sticks to Its Sell Rating for Ginkgo Bioworks Holdings (DNA)

TIPRANKS
·
26 Feb

Stock Track | Ginkgo Bioworks Plunges 12.63% in Pre-Market on Wider Losses, Weak 2025 Outlook, and Restructuring Costs

Stock Track
·
26 Feb

Stock Track | Ginkgo Bioworks Plunges 14.29% on Weak 2025 Outlook, Restructuring Costs

Stock Track
·
26 Feb

Ginkgo Bioworks Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Stock Track | Ginkgo Bioworks Plunges 12.63% After-Hours on Weak 2025 Outlook and Restructuring Costs

Stock Track
·
26 Feb

Ginkgo Bioworks Holdings Q4 EPS $(2.00) Misses $(1.77) Estimate, Sales $43.85M Miss $44.46M Estimate

Benzinga
·
26 Feb